Work

Final analysis of overall survival in OCEANS, a randomized phase III trial of gemcitabine, carboplatin, and bevacizumab followed by bevacizumab until disease progression in patients with platinum-sensitive recurrent ovarian cancer

Year: 2014

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2014.03.157

Authors: C. Aghajanian, B.A. Goff, L.R. Nycum, Y. Wang, A. Husain, S.V. Blank

Institutions: Memorial Sloan Kettering Cancer Center, University of Washington Medical Center, Novant Health Forsyth Medical Center, Genentech, New York University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1997961771

FWCI: 2.058

Cites:

Cited by: 8

Related to: 10